StrainX Bioworks raises $13M series a
StrainX Bioworks raised $13M in series a funding, announced on 26 May 2026, led by Prime Venture Partners, Leo Capital, with participation from Good Startup, Sparrow Capital, Sun Icon Ventures, Dholakia Ventures, WindT (IIT Delhi) Angels. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
Synthetic biology and precision fermentation platform focused on food, nutraceuticals and personal care industries. StrainX Bioworks is based in India and currently at series a stage, operating in deeptech, biotech.
This funding event is a citable node in Fusion42's market graph: it links StrainX Bioworks's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur, Fusion42's AI co-founder, reasons over when benchmarking a founder's own raise against what is closing in the market right now.
Round details
| Company | StrainX Bioworks |
| Stage | series a |
| Amount | $13M |
| Announced | 26 May 2026 |
| Lead | Prime Venture Partners, Leo Capital |
| Participation | Good Startup, Sparrow Capital, Sun Icon Ventures, Dholakia Ventures, WindT (IIT Delhi) Angels |
| Source | announcement ↗ |
Explore: Biotech · Series A · India
Frequently asked questions
- How much did StrainX Bioworks raise?
- StrainX Bioworks raised $13M in its series-a round, announced 2026-05-26.
- Who invested in StrainX Bioworks's series-a round?
- The round was led by Prime Venture Partners and Leo Capital, with participation from Good Startup, Sparrow Capital, Sun Icon Ventures, Dholakia Ventures and WindT (IIT Delhi) Angels.
- What does StrainX Bioworks do?
- Synthetic biology and precision fermentation platform focused on food, nutraceuticals and personal care industries.
Verified 29 May 2026 · Sources: public filings